Inflammation: The underlying foe in renovascular hypertension?

Journal of Hypertension

Volumn 27, Issue 10, 2009, Pages 1964-1965

  Johns, Edward J ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDARIT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

DRUG MECHANISM; INFLAMMATION; KIDNEY ARTERY STENOSIS; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENOVASCULAR HYPERTENSION;

EID: 70350444426     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328331a881     Document Type: Note

References (4)

1. Collins AJ, Li S, Gilbertson DT, Lui J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 2003; 64 (Suppl 87):S24-S31.
2. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 2007; 292:F330-F339.
3. Zoja C, Corna D, Benedetti G, Morigi M, Donadelli R, Guglielmotti A, et al. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. Kidney Int 1998; 53:726-734. (Pubitemid 28124289)
4. Zhu X-Y, Chade AR, Krier J, Daghini E, Lavi R, Guglielmotti A, et al. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 2009; 27:2063-2073.